How are new medicines approved by EMA?
Find out what it takes to develop a medicine and to get it authorised
All medicines must be authorised before they can be marketed and made available to patients in the European Union (EU).
When all the relevant information has been collected from laboratory tests and clinical trials, the European Medicine’s Agency’s (EMA) scientific committees conduct a comprehensive scientific evaluation of the data and provide independent recommendations on medicines for human and veterinary use.
If the benefits of the medicine are greater than its risks, EMA gives the green light and recommends to the European Commission that the medicine can be marketed across the EU, as well as in the European Economic Area.
Once the medicine is on the market, the Agency continues to monitor its safety.
For an easy introduction to the evaluation and approval of medicines, watch this video.
For further information, see our webpage on the authorisation of medicines in the EU.
Latest News from
Speech by President von der Leyen to the Hydrogen Council19/01/2021 16:33:00
Speech given by President von der Leyen to the Hydrogen Council.
Invitation letter by President Charles Michel to the members of the European Council ahead of their video conference of 21 January 202119/01/2021 15:25:00
Invitation letter given yesterday by President Charles Michel to the members of the European Council ahead of their video conference of 21 January 2021.
Remarks by Commissioner Gentiloni at the Eurogroup press conference19/01/2021 13:25:00
Remarks given yesterday by Commissioner Gentiloni at the Eurogroup press conference.
Commission takes further steps to foster the openness, strength and resilience of Europe's economic and financial system19/01/2021 12:38:00
The European Commission yesterday presented a new strategy to stimulate the openness, strength and resilience of the EU's economic and financial system for the years to come.
Arms exports control: Council establishes a EU approach on end-user certificates19/01/2021 12:38:00
The EU will soon have a more uniform approach to the export of small arms and light weapons (SALW) and their ammunition.
Opening remarks by Commissioner Ferreira at the joint press conference with Commissioner Gabriel on the launch of the New European Bauhaus19/01/2021 11:33:00
Opening remarks by Commissioner Ferreira at the joint press conference with Commissioner Gabriel on the launch of the New European Bauhaus (18 January 2021).
New European Bauhaus: Commission launches design phase19/01/2021 09:25:00
The Commission yesterday launched the design phase of the New European Bauhaus initiative, announced by President von der Leyen in her 2020 State of the Union address.
Syrian foreign affairs minister added to EU sanctions list18/01/2021 16:33:00
The Council recently (15 January 2021) decided to add Faisal Mekdad to the list of persons subject to EU restrictive measures on Syria, in light of his recent appointment as Minister of Foreign Affairs.
Statement by President von der Leyen at the joint press conference with Prime Minister Costa on the occasion of the College visit to the Portuguese Presidency18/01/2021 15:25:00
Statement given recently (15 January 2021) by President von der Leyen at the joint press conference with Prime Minister Costa on the occasion of the College visit to the Portuguese Presidency.